Patents by Inventor Robert A. Rieger

Robert A. Rieger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR FGFR INHIBITION
    Publication number: 20250270211
    Abstract: A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
    Type: Application
    Filed: May 13, 2025
    Publication date: August 28, 2025
    Inventors: Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez, Jennifer Fulton, Tanna Bettendorf, Bradley J. Newhouse, Robert A. Rieger, Cori A. Malinky, Aaron Christopher Smith, Ravi Kumar Jalluri, Mark Joseph Chicarelli, Leah J. Salituro, Macedonio J. Mejia
  • Compounds for FGFR inhibition
    Patent number: 12351581
    Abstract: A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
    Type: Grant
    Filed: August 19, 2024
    Date of Patent: July 8, 2025
    Assignee: Cogent Biosciences, Inc.
    Inventors: Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez, Jennifer Fulton, Tanna Bettendorf, Bradley J. Newhouse, Robert A. Rieger, Cori A. Malinky, Aaron Christopher Smith, Ravi Kumar Jalluri, Mark Joseph Chicarelli, Leah J. Salituro, Macedonio J. Mejia
  • COMPOUNDS FOR FGFR INHIBITION
    Publication number: 20250066352
    Abstract: A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
    Type: Application
    Filed: August 19, 2024
    Publication date: February 27, 2025
    Inventors: Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez, Jennifer Fulton, Tanna Bettendorf, Bradley J. Newhouse, Robert A. Rieger, Cori A. Malinky, Aaron Christopher Smith, Ravi Kumar Jalluri, Mark Joseph Chicarelli, Leah J. Salituro, Macedonio J. Mejia
  • COMPOUNDS FOR FGFRS INHIBITORS
    Publication number: 20240270741
    Abstract: A compound having the following structure of Formula (I): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R5, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.
    Type: Application
    Filed: January 9, 2024
    Publication date: August 15, 2024
    Inventors: Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez, Jennifer Fulton, Tanna Bettendorf, Bradley J. Newhouse, Robert A. Rieger, Cori A. Malinky, Aaron Christopher Smith, Toya D. Scaggs, Joshua Dahlke, Ravi Kumar Jalluri, Mark Joseph Chicarelli, Leah J. Salituro, Macedonio J. Mejia, Payal Chatterjee
  • FILANESIB COMBINED WITH POMALIDOMIDE DISPLAYS ENHANCED ANTI-TUMOR ACTIVITY
    Publication number: 20150045391
    Abstract: A combination of filanesib and pomalidomide for treating patients is provided.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 12, 2015
    Inventors: Deborah A. Anderson, Michael J. Humphries, Robert A. Rieger, Lance M. Williams